Search

Your search keyword '"Martinelli E"' showing total 2,075 results

Search Constraints

Start Over You searched for: Author "Martinelli E" Remove constraint Author: "Martinelli E"
2,075 results on '"Martinelli E"'

Search Results

251. Dual inhibition of TGF-β and AXL as a novel treatment for colorectal cancer

252. GLPG 1790, a new selective EPHA2 inhibitor, is active in colorectal cancer cell lines belonging to the CMS4/mesenchymal-like subtype

253. Synergistic activity between niraparib and chemotherapy in colorectal cancer: Molecular determinants from a preclinical model

254. AXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)

255. Triple blockade of EGFR, MEK and PD-L1 as effective antitumor treatment in PD-L1 overexpressing, MEK inhibitor resistant colon cancer cells

256. Clinical practice use of liquid biopsy to identify RAS/BRAF mutational status in patients with metastatic colorectal cancer: A single institution experience

257. Optimizing treatment with anti-epidermal growth factor receptor drugs for patients with metastatic colorectal cancer: novel mechanisms of resistance beyond RAS

258. Retrospective study of Regorafenib versus Trifluridine/Tipiracil efficacy in chemorefractory metastatic colorectal cancer patients: a single Italian institution real-life clinical data

259. Treatment of sarcoptic and chorioptic mange in an alpaca (Vicugna pacos) herd with a combination of topical amitraz and subcutaneous ivermectin.

262. Pimasertib hydrochloride

264. MEMRISTOR BASED SENSOR

265. Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey

266. Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms

270. Electronic interfaces

271. A new natural compound identified through a metabolomic approach has cytotoxic activity against human colorectal cancer cell lines with acquired resistance to cetuximab

273. AXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT) + cetuximab in RAS wild type (WT) patients (pts)

274. Functional inhibition of TGF-β in colorectal cancer cells and its interaction with AXL receptor

275. Combination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four consensus molecular subtypes

276. Macrophage migration inhibitory factor overexpression is a mechanism of acquired resistance to anti-EGFR inhibitor cetuximab in human colorectal cancer cell line

277. Receptor tyrosine kinase dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated colorectal cancer cell lines

278. Combined inhibition of MEK and PI3KCA pathway induces synergic antitumor activity in HER2 amplified human colorectal cancer models

280. Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis

282. A Deep Learning Strategy for Vision-Based Evaluation on the Effect of Nanoparticles Exposure

286. Climatic and anthropogenic forcing of prehistorical vegetation succession and fire dynamics in the Lago di Como area (N-Italy, Insubria)

287. Customer-driven Supply Chains under IMP lens: a systematic literature review and conceptual framework.

288. Enabling a customer-centric Supply Chain through 3D printing: an aerospace case study

290. Use of hyperspectral imaging to monitor the effectiveness of plasma-generated atomic oxygen for non-contact cleaning of indigo dyed silk

291. 397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study

293. NUMERICAL SIMULATION OF THE FATIGUE BEHAVIOUR OF FRP STRIPS GLUED TO A BRITTLE SUBSTRATE

299. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

Catalog

Books, media, physical & digital resources